VP of Mass Spectrometry Technology & Biomarkers Olaris, Inc. Framingham, Massachusetts
Metabolomics is the fields of ‘omics’ research concerned with the comprehensive characterization of the small molecule metabolites in biological systems. It is poised to provide new insights in drug discovery, diagnostics, and precision medicine. As will be discussed in the presentation, It can do so in a variety of ways and the context-of-use should guide the analytical approach taken. I will (I) provide specific examples of how metabolomics contributes to drug discovery and diagnostics, (2) introduce the work we are doing at Olaris to develop new precision diagnostics and how that guides development of a highly standardized metabolomics platform, and (3) show examples of current diagnostics under development.
Learning Objectives:
Upon completion, participants will understand how metabolomics contributes to drug development, diagnostics, and precision medicine
Upon completion, participants will appreciate the importance of highly standardized/ quantitative metabolomics approachs for diagnostics and precision medicine purposes
Upon completion, participants will understand how to setup standardized/quantitative LC-MS metabolomics methods